• Medstrada

    Food. Nutrition. Technologies

  • INVESTMENT THEMES

    NOVEL FOOD
    Personalized Nutrition
    Data and Analytics
    Healthy planet

  • News

    Cornel University and medstrada announce partnership

  • Our Vision

    Healthy Food
    Healthy Living
    Healthy Planet

About Us

Prof. Dror Haratz MD, CEO of VBL Therapeutics (NASDQ:VBLT) has over 20 years of both research in the field of medicine and biotechnology as well as a strong background in management of early to mid stage biotechnology companies.

Prof. Harats is also an experienced consultant specializing in Biotechnology / Pharmaceutical / food companies. Dror, is a professor of medicine in the department of internal medicine and the department of human molecular genetics and biochemistry at the Sackler Faculty of Medicine, Tel-Aviv University, is the head of the Bert Strassburger Lipid Center and the chairman of the IRB committee of the Sheba Medical Center.

For the past 25 years Prof. Harats has been involved in “cutting edge” Research in Lipid Metabolism, Atherosclerosis and Vascular Biology. Prof. Harats is a KOL in the field of dyslipidemia and atherosclerosis both in Israel and abroad.

Prof. Harats published more than 165 peer-reviewed research papers and chapters in books, his publications rewarded him with numerous prizes and grants.

Investment Themes

MANAGEMENT TEAM

HEALTH / NUTRITION VENTURE ADVISORS

Portfolio

Coming soon

NEWS

Cornell University and Venture Capital Fund Medstrada Announces Partnership
Medstrada  /  September 2018
Ruti Alon unveils food-tech VC fund Medstrada
Globes Online  /  September 2018

Contact Us